News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
FDA
Johnson & Johnson Gets FDA OK To Market Carotid Artery Treatment
September 26, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
CHICAGO, Sept 26 (Reuters) - Johnson & Johnson (JNJ.N: Quote, Profile, Research) said on Tuesday U.S. regulators have approved its treatment for clogged neck arteries, a condition that could lead to stroke.
>>>
Discuss This Story
Twitter
LinkedIn
Facebook
Email
Print
FDA
Approvals
Johnson & Johnson Family of Companies
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Approvals
Ascendis Enters Achondroplasia Arena as FDA Approves First Weekly Drug
March 2, 2026
·
2 min read
·
Tristan Manalac
Regulatory
FDA Action Alert: BMS, GSK, Aldeyra and More
March 2, 2026
·
4 min read
·
Tristan Manalac
FDA
FDA To Offer Bonus Payments for Speedy Drug Reviewers
February 27, 2026
·
1 min read
·
Annalee Armstrong
Approvals
Boehringer Wins Speedy Lung Cancer Approval Under Commissioner’s Priority Program
February 27, 2026
·
2 min read
·
Tristan Manalac